Clonazepam for neuropathic pain and fibromyalgia in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2012, Pages

  Corrigan, Ruth ^a   Derry, Sheena ^a   Wiffen, Philip J ^a   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; PLACEBO; ANALGESIC AGENT; ANTICONVULSIVE AGENT;

ADULT; ANALGESIC ACTIVITY; CANCER RELATED NEUROPATHY; COMPLEX REGIONAL PAIN SYNDROME; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EVIDENCE BASED MEDICINE; FIBROMYALGIA; GUILLAIN BARRE SYNDROME; HIV RELATED NEUROPATHY; HUMAN; NEUROPATHIC PAIN; NEUROPATHY; OUTCOME ASSESSMENT; PHANTOM PAIN; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIGEMINUS NEURALGIA; ANALGESIA; METHODOLOGY; NEURALGIA;

ADULT; ANALGESICS; ANTICONVULSANTS; CLONAZEPAM; FIBROMYALGIA; HUMANS; NEURALGIA; PAIN MANAGEMENT;

EID: 84864498087     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009486.pub2     Document Type: Review

References (41)

1. Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004;108:51-7. 2844269
2. Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double blind pilot study. Journal of Craniomandibular Disorders: Facial and Oral Pain 1991;5:179-86. 2844271
3. Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. Journal of Orofacial Pain 2002;16:64-70. 2844273
4. American Academy of Neurology. Treatment of painful diabetic neuropathy. www.aan.com/globals/axon/assets/8400.pdf (accessed 10 November 2011).
5. Binder RL. Three case reports of behavioral disinhibition with clonazepam. General Hospital Psychiatry 1987;9(2):151-3.
6. Birse F, Derry S, Moore RA. Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2012, Issue 5.
7. Joint Formulary Committee. Clonazepam. British National Formulary (online ed): http://bnf.org/bnf/bnf/current/3577.htm (accessed 9 November 2011). Vol. 62, London: BMJ Group and Pharmaceutical Press, September 2011:Section 4.8.1.
8. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;236(3):380-7. [DOI: 10.1016/j.pain.2007.08.013]
9. Chou R, Norris SL, Carson S, Chan BKS. Drug class review on drugs for neuropathic pain: final report. Drug Class Reviews. Portland: Oregon Health and Science University, 2007.
10. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21. [DOI: 10.1016/j.jpain.2007.09.005]
11. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-81. [DOI: 10.1016/j.pain.2010.06.019]
12. Gustorff B, Dorner T, Likar R, Grisold W, Lawrence K, Schwarz F, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica 2008;52(1):132-6.
13. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122(1-2):156-62. [DOI: 10.1016/j.pain.2006.01.030]
14. Jensen TS, Madsen CS, Finnerup NB. Pharmacology and treatment of neuropathic pains. Current Opinion in Neurology 2009;22:467-74. [DOI: 10.1097/WCO.0b013e3283311e13]
15. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain 2011;152(10):2204-5. [DOI: 10.1016/j.pain.2011.06.017]
16. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
17. Martin WJJM, Forouzanfar T. The efficacy of anticonvulsants on orofacial pain: a systematic review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2011;111:627-33. [DOI: 10.1016/j.tripleo.2011.01.033]
18. McQuay H, Carroll D, Jada AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047-52.
19. McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998. [ISBN: 0-19-263048-2]
20. McQuay HJ, Smith LA, Moore RA. Chronic pain. In: Stevens A, Raferty J, Mant J, Simpson S editor(s). Health Care Needs Assessment. Oxford: Radcliffe Publishing Ltd, 2007:519-600. [ISBN: 978-1-84619-063-6]
21. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
22. Moore RA, Edwards JE, McQuay HJ. Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain 2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]
23. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2]
24. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2009;69(2):374-9. [DOI: 10.1136/ard.2009.107805]
25. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076]
26. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. ACTINPAIN Writing Group of the IASP Special Interest Group on Systematic Reviews in Pain Relief, Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors. "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. [DOI: 10.1016/j.pain.2010.05.011]
27. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
28. National Institute for Health and Clinical Excellence. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. http://www.nice.org.uk/nicemedia/live/12948/47949/47949.pdf 2010.
29. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2007;103 Suppl(S39):e1-13. [DOI: 10.1016/j.tripleo.2006.11.009]
30. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
31. Reyes Del Paso GA, Pulgar A, Duschek S, Garrido S. Cognitive impairment in fibromyalgia syndrome: the impact of cardiovascular regulation, pain, emotional disorders and medication. European Journal of Pain 2012;16(3):421-9. [DOI: 10.1002/j.1532-2149.2011.00032.x]
32. Rothschild AJ, Shindul-Rothschild, Viguera A, Murray M, Brewster S. Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients. Journal of Clinical Psychopharmacology 2000;20(1):7-11.
33. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2]
34. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. British Journal Clinical Pharmacology 2008;66(2):266-75. [DOI: 10.1111/j.1365-2125.2008.03200.x]
35. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008;8:29. [DOI: 10.1186/1471-2377-8-29]
36. Tremont-Lukats IW, Megeff C, Backonja M. Anticonvulsants for neuropathic pain syndromes. Drugs 2000;60:1029-52.
37. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2]
38. Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD006044.pub3]
39. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990;33:160-72.
40. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 2010;62(5):600-10. [DOI: 10.1002/acr.20140]
41. Wiffen PJ, Collins S, McQuay HJ, Carroll D, Jadad A, Moore RA. WITHDRAWN. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD001133.pub3]